261Y000240/35361 - Amoxicillin 875 mg + clavulanic acid -2023/671

This tender concerns the procurement of a specific pharmaceutical product: 'Amoxicillin 875 mg + clavulanic acid'. The reference numbers 261Y000240/35361 and 2023/671 likely identify this specific acquisition within a larger framework or catalog. Amoxicillin and clavulanic acid is a combination antibiotic commonly used to treat a variety of bacterial infections. This tender is likely issued by a healthcare provider, hospital, pharmacy, or public health agency seeking to purchase this medication. The requirements will specify the dosage, form (e.g., tablets, capsules), packaging, quantities, and delivery conditions. Bidders must be authorized pharmaceutical suppliers capable of providing genuine, high-quality medication that meets all regulatory standards. This procurement ensures the availability of essential antibiotics for patient treatment. The tender documents will provide detailed specifications and evaluation criteria.

This is a supplies contract in the health and medical services, Monitoring Evaluation and general supplies sectors. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 240.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.